Navigation Links
Landmark report reveals immense burden of osteoporotic fractures in Europe
Date:6/15/2011

A new report launched today by the International Osteoporosis Foundation (IOF) in collaboration with the European Federation of Pharmaceutical Industry Associations (EFPIA) reveals that the burden of fractures in Europe has been vastly underestimated. The report concludes that in Europe's five largest countries and Sweden alone, an estimated 2.5 million new fragility fractures occurred in 2010 the equivalent of 280 fractures per hour. It also showed an astounding eighty deaths per day attributable to fragility fractures.

'Osteoporosis: Burden, health care provision and opportunities in the European Union' examines both epidemiological and health economic aspects of osteoporosis and osteoporotic fractures in Europe, and specifically in France, Germany, Italy, Spain, UK as well as Sweden.

It is estimated that one in three women and one in five men over the age of fifty worldwide will sustain an osteoporotic fracture, often resulting in substantial pain and suffering, disability, and even death. As a result, osteoporosis imposes a significant burden on both the individual and society. IOF President John Kanis stated, "This landmark report exposes a number of major issues and challenges related to health care provision for fragility fractures. What is particularly striking is how the economic burden of fractures has increased in just over a decade. In 2000 the economic burden of fractures for the then European Union was estimated at 36 billion. The current estimate of 30.7 billion for just six countries largely reflects the increased number of fractures due to Europe's ageing population."

Several of the key findings regarding the economic and health cost of fragility fractures for the six countries studied include:

  • For the year 2010 approximately 2.5 million new fractures occurred in the six countries, with approximately 34,000 deaths caused by fractures 49% following hip fractures
  • The total health burden of osteoporotic fractures, measured in quality-adjusted life years (QALY) lost, was estimated at approximately 850,000 QALYs.
  • The health care cost, including pharmacological prevention, was estimated at Euro 30.7 billion corresponding to 3.5% of the total spending on health care in those countries.
  • A majority of the total costs was for the acute management of fracture whilst pharmacological prevention and treatment only represented 4.7% of total costs.
  • Despite the existence of management guidelines, a minority of patients receive medical treatment to prevent fractures.
  • In 2025 the projected number of fractures will increase by 29% reaching 3.2 million fractures, with health care costs increasing to Euro 38.5 billion.
  • Improved implementation of clinical guidelines to close this 'treatment gap' is cost-effective and could save almost 700,000 fractures by 2025.
  • The economic burden of osteoporotic fractures in these countries exceeds those for migraine, stroke, MS, and Parkinson's disease, and is similar to the burden of rheumatoid arthritis.

In six clearly defined chapters, it provides an introduction to osteoporosis and then reviews medical innovation and clinical progress in the management of osteoporosis, the epidemiology and burden of the disease, the current uptake of osteoporosis treatments and the future burden of fractures as a consequence of increasing treatment uptake.

EFPIA Director General Richard Bergstrm commented, " In Europe the number of elderly is set to increase markedly, with individuals expected to enjoy a longer life expectancy than ever before. We also know that the incidence of fractures rises progressively with age, and as a result we can expect the economic and social impact of fractures to increase significantly unless action is taken. Fortunately, we have a host of effective diagnostic and treatment options at our disposal it is time to implement these advances fully. "


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. OHSU Doernbecher Childrens Hospital conducts second phase of landmark Batten study
2. Terumo Medical Corp. reports first US implant in landmark study enrolling in US and Japan
3. Fruit flies use horizontal landmarks for altitude control, says Caltech research team
4. Landmark dental school study uses genetic test to help predict gum disease
5. Scripps Research team wins global race to achieve landmark synthesis of perplexing natural product
6. Moa get fewer: Landmark study
7. Carnegie donates landmark clones to biology
8. Landmark project to map genomics of complex ant systems
9. ACLU -- Myriad Genetics lawsuit will become landmark case
10. 150 years of Darwins landmark book spawns international conference
11. Landmark national study reveals significance of green practices in attractions industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: